P2Y2 receptor activation by nucleotides released from highly metastatic breast cancer cells increases tumor growth and invasion via crosstalk with endothelial cells

Breast Cancer Research

Volumn 16, Issue 5, 2014, Pages

  Jin, Hana ^a   Eun, So Y ^a   Lee, Jong S ^a   Park, Sang W ^a   Lee, Jae H ^a   Chang, Ki C ^a   Kim, Hye J ^a  

^a Gyeongsang National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CADHERIN; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; NUCLEOTIDE; PURINERGIC P2Y2 RECEPTOR; SHORT HAIRPIN RNA; URIDINE TRIPHOSPHATE; VASCULOTROPIN; LEUKOCYTE ANTIGEN; MMP9 PROTEIN, HUMAN; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; BREAST METASTASIS; CANCER CELL LINE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN PHOSPHORYLATION; TUMOR GROWTH; TUMOR INVASION; ANIMAL; BIOSYNTHESIS; BREAST TUMOR; CANCER TRANSPLANTATION; CELL COMMUNICATION; CELL MOTION; FEMALE; LUNG TUMOR; MCF 7 CELL LINE; METABOLISM; NUDE MOUSE; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING; SECONDARY;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIGENS, CD; BREAST NEOPLASMS; CADHERINS; CELL COMMUNICATION; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL CELLS; FEMALE; HUMANS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 9; MCF-7 CELLS; MICE, NUDE; NEOPLASM TRANSPLANTATION; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, PURINERGIC P2Y2; URIDINE TRIPHOSPHATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84908207581     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3694     Document Type: Article

References (47)

1. Bergfeld GR, Forrester T. Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. Cardiovasc Res 1992, 26:40-47. 10.1093/cvr/26.1.40, 1325292.
2. Ciccarelli R, Di Iorio P, Giuliani P, D'Alimonte I, Ballerini P, Caciagli F, Rathbone MP. Rat cultured astrocytes release guanine-based purines in basal conditions and after hypoxia/hypoglycemia. Glia 1999, 25:93-98. 10.1002/(SICI)1098-1136(19990101)25:1<93::AID-GLIA9>3.0.CO;2-N, 9888301.
3. Pedersen S, Pedersen SF, Nilius B, Lambert IH, Hoffmann EK. Mechanical stress induces release of ATP from Ehrlich ascites tumor cells. Biochim Biophys Acta 1999, 1416:271-284. 10.1016/S0005-2736(98)00228-4, 9889382.
4. Bodin P, Burnstock G. Purinergic signalling: ATP release. Neurochem Res 2001, 26:959-969. 10.1023/A:1012388618693, 11699948.
5. Pellegatti P, Raffaghello L, Bianchi G, Piccardi F, Pistoia V, Di Virgilio F. Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS One 2008, 3:e2599. 10.1371/journal.pone.0002599, 2440522, 18612415.
6. Di Virgilio F, Chiozzi P, Falzoni S, Ferrari D, Sanz JM, Venketaraman V, Baricordi OR. Cytolytic P2X purinoceptors. Cell Death Differ 1998, 5:191-199. 10.1038/sj.cdd.4400341, 10200464.
7. Di Virgilio F, Ferrari D, Adinolfi E. P2X7: a growth-promoting receptorimplications for cancer. Purinergic Signal 2009, 5:251-256. 10.1007/s11302-009-9145-3, 2686832, 19263244.
8. Adinolfi E, Callegari MG, Ferrari D, Bolognesi C, Minelli M, Wieckowski MR, Pinton P, Rizzuto R, Di Virgilio F. Basal activation of the P2X7 ATP receptor elevates mitochondrial calcium and potential, increases cellular ATP levels, and promotes serum-independent growth. Mol Biol Cell 2005, 16:3260-3272. 10.1091/mbc.E04-11-1025, 1165409, 15901833.
9. White N, Butler PE, Burnstock G. Human melanomas express functional P2X(7) receptors. Cell Tissue Res 2005, 321:411-418. 10.1007/s00441-005-1149-x, 15991050.
10. Schafer R, Sedehizade F, Welte T, Reiser G. ATP- and UTP-activated P2Y receptors differently regulate proliferation of human lung epithelial tumor cells. Am J Physiol Lung Cell Mol Physiol 2003, 285:L376-L385.
11. Shabbir M, Ryten M, Thompson C, Mikhailidis D, Burnstock G. Purinergic receptor-mediated effects of ATP in high-grade bladder cancer. BJU Int 2008, 101:106-112.
12. Janssens R, Boeynaems JM. Effects of extracellular nucleotides and nucleosides on prostate carcinoma cells. Br J Pharmacol 2001, 132:536-546. 10.1038/sj.bjp.0703833, 1572579, 11159704.
13. Maaser K, Höpfner M, Kap H, Sutter AP, Barthel B, von Lampe B, Zeitz M, Scherübl H. Extracellular nucleotides inhibit growth of human oesophageal cancer cells via P2Y(2)-receptors. Br J Cancer 2002, 86:636-644. 10.1038/sj.bjc.6600100, 2375265, 11870549.
14. Katzur AC, Koshimizu T, Tomić M, Schultze-Mosgau A, Ortmann O, Stojilkovic SS. Expression and responsiveness of P2Y2 receptors in human endometrial cancer cell lines. J Clin Endocrinol Metab 1999, 84:4085-4091. 10.1210/jcem.84.11.6119, 10566654.
15. Höpfner M, Lemmer K, Jansen A, Hanski C, Riecken EO, Gavish M, Mann B, Buhr H, Glassmeier G, Scherübl H. Expression of functional P2-purinergic receptors in primary cultures of human colorectal carcinoma cells. Biochem Biophys Res Commun 1998, 251:811-817. 10.1006/bbrc.1998.9555, 9790992.
16. Hayes DF, Isaacs C, Stearns V. Prognostic factors in breast cancer: current and new predictors of metastasis. J Mammary Gland Biol Neoplasia 2001, 6:375-392. 10.1023/A:1014778713034, 12013528.
17. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108. 10.3322/canjclin.55.2.74, 15761078.
18. Lu X, Kang Y. Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clin Cancer Res 2010, 16:5928-5935. 10.1158/1078-0432.CCR-10-1360, 3005023, 20962028.
19. Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PF. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 1995, 376:517-519. 10.1038/376517a0, 7543654.
20. Gho YS, Kim PN, Li HC, Elkin M, Kleinman HK. Stimulation of tumor growth by human soluble intercellular adhesion molecule-1. Cancer Res 2001, 61:4253-4257.
21. Fox SB, Turner GD, Gatter KC, Harris AL. The increased expression of adhesion molecules ICAM-3, E-selectin and P-selectins on breast cancer endothelium. J Pathol 1995, 177:369-376. 10.1002/path.1711770407, 8568591.
22. Christiansen I, Sundstrom C, Totterman TH. Elevated serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) closely reflect tumour burden in chronic B-lymphocytic leukaemia. Br J Haematol 1998, 103:1129-1137. 10.1046/j.1365-2141.1998.01110.x, 9886331.
23. Wang X, Clowes C, Duarte R, Pu QQ. Serum ICAM-1 concentrations following conventional dose consolidation chemotherapy for acute myeloid leukemia and after high dose chemotherapy with autologous haematopoietic stem cell rescue. Int J Oncol 2000, 17:591-595.
24. Maeda K, Kang SM, Sawada T, Nishiguchi Y, Yashiro M, Ogawa Y, Ohira M, Ishikawa T, Hirakawa YS, Chung K. Expression of intercellular adhesion molecule-1 and prognosis in colorectal cancer. Oncol Rep 2002, 9:511-514.
25. Nguyen M, Corless CL, Kraling BM, Tran C, Atha T, Bischoff J, Barsky SH. Vascular expression of E-selectin is increased in estrogen-receptor-negative breast cancer: a role for tumor-cell-secreted interleukin-1 alpha. Am J Pathol 1997, 150:1307-1314. 1858186, 9094987.
26. Zhang GJ, Adachi I. Serum levels of soluble intercellular adhesion molecule-1 and E-selectin in metastatic breast carcinoma: correlations with clinicopathological features and prognosis. Int J Oncol 1999, 14:71-77.
27. Thompson EW, Price JT. Mechanisms of tumour invasion and metastasis: emerging targets for therapy. Expert Opin Ther Targets 2002, 6:217-233. 10.1517/14728222.6.2.217, 12223082.
28. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 2001, 357:539-545. 10.1016/S0140-6736(00)04046-0, 11229684.
29. Dejana E, Orsenigo F, Lampugnani MG. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 2008, 121:2115-2122. 10.1242/jcs.017897, 18565824.
30. Keen JC, Davidson NE. The biology of breast carcinoma. Cancer 2003, 97:825-833. 10.1002/cncr.11126, 12548582.
31. Anandappa SY, Sibson R, Platt-Higgins A, Winstanley JH, Rudland PS, Barraclough R. Variant estrogen receptor α mRNAs in human breast cancer specimens. Int J Cancer 2000, 88:209-216. 10.1002/1097-0215(20001015)88:2<209::AID-IJC10>3.0.CO;2-M, 11004670.
32. Nizamutdinova IT, Lee GW, Lee JS, Cho MK, Son KH, Jeon SJ, Kang SS, Kim YS, Lee JH, Seo HG, Chang KC, Kim HJ. Tanshinone I suppreses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules. Carcinogenesis 2008, 29:1885-1892. 10.1093/carcin/bgn151, 18586687.
33. Jin H, Ham SA, Kim MY, Woo IS, Kang ES, Hwang JS, Lee KW, Kim HJ, Roh GS, Lim DS, Kang D, Seo HG. Activation of peroxisome proliferator-activated receptor-δ attenuates glutamate-induced neurotoxicity in HT22 mouse hippocampal cells. J Neurosci Res 2012, 90:1646-1653. 10.1002/jnr.23053, 22473775.
34. Suganuma M, Okabe S, Marino MW, Sakai A, Sueoka E, Fujiki H. Essential role of tumor necrosis factor alpha (TNF-alpha) in tumor promotion as revealed by TNF-alpha-deficient mice. Cancer Res 1999, 59:4516-4518.
35. Egberts JH, Cloosters V, Noack A, Schniewind B, Thon L, Klose S, Kettler B, von Forstner C, Kneitz C, Tepel J, Adam D, Wajant H, Kalthoff H, Trauzold A. Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis. Cancer Res 2008, 68:1443-1450. 10.1158/0008-5472.CAN-07-5704, 18316608.
36. Luga V, Zhang L, Viloria-Petit AM, Ogunjimi AA, Inanlou MR, Chiu E, Buchanan M, Hosein AN, Basik M, Wrana JL. Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 2012, 151:1542-1556. 10.1016/j.cell.2012.11.024, 23260141.
37. Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 2010, 10:9-22. 10.1038/nrc2748, 20029421.
38. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009, 9:239-252. 10.1038/nrc2618, 3251309, 19279573.
39. Yilmaz M, Christofori G, Lehembre F. Distinct mechanisms of tumor invasion and metastasis. Trends Mol Med 2007, 13:535-541. 10.1016/j.molmed.2007.10.004, 17981506.
40. Kawai Y, Kaidoh M, Ohhashi T. MDA-MB-231 produces ATP-mediated ICAM-1-dependent facilitation of the attachment of carcinoma cells to human lymphatic endothelial cells. Am J Physiol Cell Physiol 2008, 295:C1123-C1132. 10.1152/ajpcell.00247.2008, 18768924.
41. White N, Burnstock G. P2 receptors and cancer. Trends Pharmacol Sci 2006, 27:211-217. 10.1016/j.tips.2006.02.004, 16530853.
42. Chadet S, Jelassi B, Wannous R, Angoulvant D, Chevalier S, Besson P, Roger S. The activation of P2Y2 receptors increases MCF-7 breast cancer cells migration through the MEK-ERK1/2 signalling pathway. Carcinogenesis 2014, 35:1238-1247. 10.1093/carcin/bgt493, 24390819.
43. Blood CH, Zetter BR. Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Bichim Biophys Acta 1990, 1032:89-118.
44. Herren B, Levkau B, Raines EW, Ross R. Cleavage of beta-catenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis: evidence for a role for caspases and metalloproteinases. Mol Biol Cell 1998, 9:1589-1601. 10.1091/mbc.9.6.1589, 25388, 9614196.
45. Luplertlop N, Missé D, Bray D, Deleuze V, Gonzalez JP, Leardkamolkarn V, Yssel H, Veas F. Dengue-virus-infected dendritic cells trigger vascular leakage through metalloproteinase overproduction. EMBO Rep 2006, 7:1176-1181. 10.1038/sj.embor.7400814, 1679776, 17028575.
46. Inai T, Mancuso M, Hashizume H, Baffert F, Haskell A, Baluk P, Hu-Lowe DD, Shalinsky DR, Thurston G, Yancopoulos GD, McDonald DM. Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. Am J Pathol 2004, 165:35-52. 10.1016/S0002-9440(10)63273-7, 1618540, 15215160.
47. Schumacher D, Strilic B, Sivaraj KK, Wettschureck N, Offermanns S. Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor. Cancer Cell 2013, 24:130-137. 10.1016/j.ccr.2013.05.008, 23810565.